Skip to main content
. 2015 Sep 14;15:219. doi: 10.1186/s12884-015-0650-9

Table 2.

Birthplace outcomes – all women followed up (n = 700)

Misoprostol Placebo Relative risk (95 % CI)
Sample size 345 355
Final place of delivery (n, %)
Hospital 102 (29.6) 114 (32.1) ---
Government or private clinic 93 (27.0) 92 (25.9) 1.065 (0.871 : 1.302)
Home (own/family member) 125 (36.2) 120 (33.8) 1.076 (0.892 : 1.298)
House of friend or TBA 16 ( 4.6) 19 ( 5.4) 0.968 (0.657 : 1.462)
Other* 9 ( 2.6) 10 ( 2.8) 1.059 (0.668 : 1.678)
Number of babies delivered (n, %)
1 338 (98.0) 347 (97.7) ---
2 or more 7 ( 2.0) 8 ( 2.3) 1.002 (0.981 : 1.024)
Mode of delivery (n, %)
Normal vaginal delivery 328 (95.1) 341 (96.1) ---
Caesarean section 16 ( 4.6) 14 ( 3.9) 1.088 (0.772 : 1.534)
Instrumental delivery 1 ( 0.3) 0 ---
Person assisting with the birth**(n, %)
Doctor and/or trained midwife 196 (56.8) 207 (58.3) 0.970 (0.836 : 1.125)
Traditional birth attendant 37 (10.7) 39 (11.0) 0.987 (0.782 : 1.245)
Family member and/or friend 106 (30.7) 103 (29.0) 1.041 (0.885 : 1.225)
No-one 12 ( 3.5) 13 ( 3.7) 0.974 (0.664 : 1.410)
Village Health team / Nursing assistant 3 ( 0.9) 4 ( 1.1) 0.886 (0.465 : 1.691)
Study medication taken (n, %) 204 (59.1) 193 (54.4) 1.088 (0.955 : 1.238)
If medication taken when did you take them? (n, %)
Before labour started 1 ( 0.5) 0 ---
During labour 1 ( 0.5) 0 ---
Immediately after delivery (before placenta) 97 (47.5) 103 (53.4) ---
Immediately after delivery (after placenta) 102 (50.0) 87 (45.1) 1.113 (0.916 : 1.351)
1–24 hours after delivery 3 ( 1.5) 3 ( 1.6) 1.031 (0.457 : 2.324)

* : 14 mothers delivered en-route to hospital; 5 mothers delivered at the home of an unspecified health professional

** : more than one response possible so numbers do not total 100 %

† : two participants in the placebo arm recorded singleton births but stated verbally later that they delivered twins. They are both added to the multiple birth group in this table